Altamira Therapeutics Ltd. — 424B5 Filings
12 424B5 filings on record
This page lists all 424B5 filings submitted to the SEC by Altamira Therapeutics Ltd. (CYTOF), sorted by most recent first. Each row links to the full filing on EdgarLookup. Altamira Therapeutics Ltd. has filed 12 424B5 documents with the SEC since 2014. To view all SEC filings by Altamira Therapeutics Ltd., see the full filings list.
All
15-12G
15F-12B
20-F
20-F/A
25-NSE
424B3
424B4
424B5
6-K
6-K/A
8-A12B
8-A12B/A
8-K12G3
CERT
CERTNAS
CORRESP
CT ORDER
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
F-4
F-4/A
FWP
NT 20-F
POS AM
POS EX
RW
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-24-004900 | Jan 19, 2024 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-21-064202 | Dec 8, 2021 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-21-002553 | Jan 15, 2021 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-20-040801 | Dec 3, 2020 | — |
| 424B5 | FORM 424B5 | 0000950103-18-014618 | Dec 13, 2018 | — |
| 424B5 | FORM 424B5 | 0000950103-18-013933 | Nov 30, 2018 | — |
| 424B5 | FORM 424B5 | 0000950103-18-013783 | Nov 29, 2018 | — |
| 424B5 | FORM 424B5 | 0000950103-18-000958 | Jan 29, 2018 | — |
| 424B5 | FORM 424B5 | 0000950103-17-009902 | Oct 11, 2017 | — |
| 424B5 | FORM 424B5 | 0000950103-17-001508 | Feb 16, 2017 | — |
| 424B5 | FORM 424B5 | 0000950103-17-001408 | Feb 14, 2017 | — |
| 424B5 | FORM 424B5 | 0000950103-16-013842 | Jun 1, 2016 | — |